Narval is pioneering a new generation of antibody drugs using synthetic proteins that mimic the activity of antibodies and can be delivered through mucosal and skin tissues to treat diseases on the eyes, lungs, and skin.
Company Details
- Employees
- 4
- Founded
- -
- Address
- Knoxville, Tennessee, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://narvalbio.com/
- Keywords
- Antibody Engineering, Antibody-like proteins, Life Sciences, Biotechnology, Biopharmaceuticals, Immunotherapeutics, Antibody drugs.
- HQ
- Knoxville, Tennessee
Narval Questions
Narval's website is https://narvalbio.com/
Narval's LinkedIn profile is https://www.linkedin.com/company/narvalbio
Narval has
4 employees.
View email and phone details for 4
employees at Narval.
Narval's industry is
Biotechnology Research
Narval's top competitors are
Typcal,
Fluvion,
The Good Pulse Company,
B-Cos,
Bugbiome,
Polymera,
Hayden Biotech,
Carapace Biopolymers,
Seedling Biosystems,
Nanosentinel Technologies.
Narval's categories are Biotechnology Research
Narval's founding year is 2023
